Literature DB >> 11462065

Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.

J K Dawson1, H E Fewins, J Desmond, M P Lynch, D R Graham.   

Abstract

BACKGROUND: Fibrosing alveolitis (FA) is a common and serious complication of rheumatoid arthritis (RA). Before the availability of high resolution computed tomographic (HRCT) scanning, it was difficult to diagnose accurately without recourse to biopsy. Prospective studies have reported a prevalence of interstitial lung disease (ILD) of 19-44%. The term ILD used by these authors encompasses a variety of appearances on HRCT scans. This prospective study used HRCT scanning to determine the true prevalence of FA in hospital outpatients with RA, and to study associated clinical characteristics.
METHODS: One hundred and fifty consecutive patients with RA were selected from a hospital outpatient department, irrespective of the presence or absence of chest disease. All underwent a detailed clinical assessment, chest HRCT scanning, and conventional chest radiography within 4 weeks of full pulmonary function tests.
RESULTS: Seventy percent of patients were current or reformed cigarette smokers. Twenty eight (19%) had FA, most frequently of reticular pattern, and 12 of this group (43%) also had emphysematous bullae. None of the previously suggested risk factors for developing FA were confirmed. Fifty four percent of patients with HRCT evidence of FA had bilateral basal chest crackles, 82% had a reduced carbon monoxide transfer factor (TLCO), 14% had restrictive pulmonary function tests, and 14% had bilateral chest radiographic signs of FA.
CONCLUSIONS: HRCT evidence of FA was present in 19% of hospital outpatients with RA. Abnormalities on chest examination or on full pulmonary function tests, even without restrictive changes or chest radiographic abnormalities, should prompt physicians to request a chest HRCT scan when investigating dyspnoea in patients with RA.

Entities:  

Mesh:

Year:  2001        PMID: 11462065      PMCID: PMC1746113          DOI: 10.1136/thorax.56.8.622

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Rheumatoid disease with joint and pulmonary manifestations.

Authors:  P ELLMAN; R E BALL
Journal:  Br Med J       Date:  1948-11-06

2.  Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease.

Authors:  S P Padley; D M Hansell; C D Flower; P Jennings
Journal:  Clin Radiol       Date:  1991-10       Impact factor: 2.350

Review 3.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Cryptogenic fibrosing alveolitis with preserved lung volumes.

Authors:  M J Doherty; M G Pearson; E A O'Grady; V Pellegrini; P M Calverley
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

5.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.

Authors:  J R Mathieson; J R Mayo; C A Staples; N L Müller
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

6.  High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease.

Authors:  J McDonagh; M Greaves; A R Wright; C Heycock; J P Owen; C Kelly
Journal:  Br J Rheumatol       Date:  1994-02

7.  Pulmonary function in patients with rheumatoid arthritis.

Authors:  P Oxholm; E B Madsen; R Manthorpe; F V Rasmussen
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

Review 8.  Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy.

Authors:  R A Roschmann; R J Rothenberg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

9.  [Plain film and CT findings of pulmonary involvement in rheumatoid arthritis].

Authors:  K Sasaka; Y Nakajima; C Kase; H Yamada
Journal:  Ryumachi       Date:  1998-10

10.  Pulmonary involvement in rheumatoid arthritis.

Authors:  P Cervantes-Perez; A H Toro-Perez; P Rodriguez-Jurado
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

View more
  70 in total

1.  How common is methotrexate pneumonitis? A large prospective study investigates.

Authors:  Navtej Sathi; Batsirai Chikura; Viswanath V Kaushik; Rose Wiswell; Julie K Dawson
Journal:  Clin Rheumatol       Date:  2011-06-03       Impact factor: 2.980

Review 2.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

3.  Is interstitial pneumonia in patients with collagen diseases a contraindication to lung cancer surgery?

Authors:  Jun Nakajima; Shinichi Takamoto; Tomohiro Murakawa; Takeshi Fukami; Atsushi Sano
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

Review 4.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

5.  Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Yongfeng Zhang; Hongbin Li; Nawei Wu; Xin Dong; Yi Zheng
Journal:  Clin Rheumatol       Date:  2017-02-12       Impact factor: 2.980

Review 6.  Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

Authors:  Aryeh Fischer; Jörg Distler
Journal:  Clin Rheumatol       Date:  2019-08-19       Impact factor: 2.980

7.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Authors:  Tim Bongartz; Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2010-06

8.  Patterns of interstitial lung disease and mortality in rheumatoid arthritis.

Authors:  Jorge A Zamora-Legoff; Megan L Krause; Cynthia S Crowson; Jay H Ryu; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2017-03-01       Impact factor: 7.580

9.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.

Authors:  J Biederer; A Schnabel; C Muhle; W L Gross; M Heller; M Reuter
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

10.  High-resolution computed tomography and rheumatoid arthritis: semi-quantitative evaluation of lung damage and its correlation with clinical and functional abnormalities.

Authors:  Baris Yilmazer; Sevtap Gümüştaş; Fulya Coşan; Nagihan İnan; Fatih Ensaroğlu; Gökhan Erbağ; Füsun Yıldız; Ayşe Çefle
Journal:  Radiol Med       Date:  2015-10-22       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.